Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving Treatment

[1]  Stuart A. Taylor,et al.  Magnetic resonance imaging for the clinical management of rectal cancer patients: recommendations from the 2012 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting , 2018, European Radiology.

[2]  G. Beets,et al.  MRI for assessing and predicting response to neoadjuvant treatment in rectal cancer , 2014, Nature Reviews Gastroenterology &Hepatology.

[3]  J. Gama-Rodrigues,et al.  Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control. , 2014, International journal of radiation oncology, biology, physics.

[4]  Yongxue Zhang,et al.  18F-FDG PET predicts pathological response to preoperative chemoradiotherapy in patients with primary rectal cancer: a meta-analysis , 2014, Annals of Nuclear Medicine.

[5]  M. Kalady,et al.  Clinical Criteria Underestimate Complete Pathological Response in Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy , 2014, Diseases of the colon and rectum.

[6]  J. Stoker,et al.  Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and meta-analysis. , 2013, Radiology.

[7]  C. Buskens,et al.  Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer , 2013, British Journal of Surgery.

[8]  T. Sagar,et al.  Complete clinical response to neoadjuvant chemoradiation in rectal cancers: can surgery be avoided? , 2013, Hepato-gastroenterology.

[9]  P. Chu,et al.  Distribution of Residual Cancer Cells in the Bowel Wall After Neoadjuvant Chemoradiation in Patients With Rectal Cancer , 2013, Diseases of the colon and rectum.

[10]  K. Goodman,et al.  Nonoperative Management of Rectal Cancer With Complete Clinical Response After Neoadjuvant Therapy , 2012, Annals of surgery.

[11]  T. Saclarides,et al.  Tumor Scatter After Neoadjuvant Therapy for Rectal Cancer: Are We Dealing with an Invisible Margin? , 2012, Diseases of the colon and rectum.

[12]  J. Gama-Rodrigues,et al.  Role of biopsies in patients with residual rectal cancer following neoadjuvant chemoradiation after downsizing: can they rule out persisting cancer? , 2012, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[13]  Geerard L Beets,et al.  Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  G. Beets,et al.  Long-term Follow-up Features on Rectal MRI During a Wait-and-See Approach After a Clinical Complete Response in Patients With Rectal Cancer Treated With Chemoradiotherapy , 2011, Diseases of the colon and rectum.

[15]  J. Park,et al.  Is step section necessary for determination of complete pathological response in rectal cancer patients treated with preoperative chemoradiotherapy? , 2011, Histopathology.

[16]  J. Baixauli,et al.  Accuracy of Endoscopic Ultrasound to Assess Tumor Response After Neoadjuvant Treatment in Rectal Cancer: Can We Trust the Findings? , 2011, Diseases of the colon and rectum.

[17]  K. Haustermans,et al.  Diffusion-Weighted MRI for Selection of Complete Responders After Chemoradiation for Locally Advanced Rectal Cancer: A Multicenter Study , 2011, Annals of Surgical Oncology.

[18]  J. Gama-Rodrigues,et al.  Complete Clinical Response After Neoadjuvant Chemoradiation Therapy for Distal Rectal Cancer: Characterization of Clinical and Endoscopic Findings for Standardization , 2010, Diseases of the colon and rectum.

[19]  Karin Haustermans,et al.  Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. , 2010, The Lancet. Oncology.

[20]  J. V. van Engelshoven,et al.  Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part II. What are the criteria to predict involved lymph nodes? , 2009, Radiology.

[21]  A. Crucitti,et al.  Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. , 2009, Radiology.

[22]  S. Laurberg,et al.  Whither papillon? Future directions for contact radiotherapy in rectal cancer. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

[23]  J. Gama-Rodrigues,et al.  Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy , 2006, Journal of Gastrointestinal Surgery.

[24]  M. Mazumdar,et al.  Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Fábio Guilherme Campos,et al.  Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation Therapy: Long-term Results , 2004, Annals of surgery.

[26]  D. Altman,et al.  Diagnostic tests 4: likelihood ratios , 2004, BMJ : British Medical Journal.

[27]  P. Romestaing,et al.  Radiotherapy alone in the curative treatment of rectal carcinoma. , 2003, The Lancet. Oncology.

[28]  P. Quirke,et al.  The prediction of local recurrence in rectal adenocarcinoma by histopathological examination , 1988, International Journal of Colorectal Disease.

[29]  J. Hanley,et al.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases. , 1983, Radiology.